Fresenius Medical Care Ag ADR (FMS) Stock Price, Quote & News

Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract...

Industry: Medical Care Facilities

Sector: Healthcare

Phone: 49 6172 609 0

Website: www.freseniusmedicalcare.com

Address:

Else-Kröner-Strasse 1, Bad Homburg, Germany

WARRENBUFFETSIGNAL Sep. 9 at 7:22 PM

$CRMD $DVA $FMS BULLISH CORMEDIX

0 · Reply

Noname2022 Sep. 9 at 6:41 PM

$CRMD $FMS $DVA Great to have patient advocacy orgs backing a life saving preventive FDA approved Defencath for CVC’s Available at Fresenius but NOT Davita!

1 · Reply

Noname2022 Sep. 5 at 11:09 PM

$CRMD $DVA $FMS Fact: DefenCath cuts infections by 71%. It’s on formulary at Fresenius — not at DaVita.

2 · Reply

Noname2022 Sep. 5 at 1:46 AM

$CRMD $FMS Defencath operationalizing aka ”patient safety initiatives” in Aug. 5th Q2 Fresenius earnings call https://freseniusmedicalcare.com/content/dam/fresenius-medical-care/global/en/03_investors/pdf/03_publications/2025/q2/FME_Q2_2025_Investor%20Presentation.pdf

0 · Reply

Noname2022 Sep. 5 at 1:24 AM

$CRMD $FMS $DVA https://www.ispor.org/heor-resources/presentations-database/presentation-cti/ispor-2025/poster-session-4/the-clinical-value-and-cost-effectiveness-of-defencath-for-reducing-catheter-related-bloodstream-infections-in-adult-patients-receiving-hemodialysis-through-a-central-venous-catheter

0 · Reply

Noname2022 Sep. 4 at 1:52 PM

$CRMD $DVA $FMS https://www.tandfonline.com/doi/abs/10.1080/17460913.2025.2547498

0 · Reply

Estimize Sep. 4 at 11:06 AM

Wall St is expecting 0.58 EPS for $FMS Q3 [Reporting 11/04 BMO] http://www.estimize.com/intro/fms?chart=historical&metric_name=eps&utm_cont

0 · Reply

Noname2022 Sep. 3 at 6:45 PM

$CRMD $FMS Reminder abour Fresenius initiative to reduce BSI’s Expecting to hear about expanded cohorts potential at these upcoming calls https://freseniusmedicalcare.com/content/dam/fresenius-medical-care/global/en/03_investors/pdf/events/cmd/2025/FME_CMD_2025_Care_Delivery_Breakout%20Session.pdf

0 · Reply

JarvisFlow Sep. 2 at 12:30 PM

UBS has adjusted their stance on Fresenius Medical Care ( $FMS ), setting the rating to Sell.

0 · Reply

Noname2022 Aug. 31 at 9:11 AM

$CRMD $FMS $DVA Just a reminder…

0 · Reply

Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework

Aug 5, 2025, 11:23 AM EDT - 5 weeks ago

Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 7:00 AM EDT - 5 weeks ago

Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025

Jul 22, 2025, 7:31 AM EDT - 7 weeks ago

Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy)

Jul 18, 2025, 4:25 AM EDT - 2 months ago

$6.3 Trillion Outpatient Clinics Markets, 2021-2024 & 2025-2029 | Profiles of Leading Players - Johns Hopkins Medicine, Mayo Clinic, MD Anderson Cancer Center, Apollo Hospital, and Fresenius Medical

Jul 3, 2025, 8:00 AM EDT - 2 months ago

Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico

Jun 17, 2025, 1:21 PM EDT - 3 months ago

Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency

Jun 17, 2025, 8:56 AM EDT - 3 months ago

Fresenius Medical Care CEO Says Company Could Benefit From Obesity Drugs

Jun 17, 2025, 7:00 AM EDT - 3 months ago

Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation

Jun 17, 2025, 4:08 AM EDT - 3 months ago

Fresenius Medical Care announces 1 bln euros share buyback programme

Jun 16, 2025, 3:06 PM EDT - 3 months ago

5 Stocks To Ride The German Market Rally

BNTX SAP

Jun 4, 2025, 8:00 AM EDT - 3 months ago

Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S.

May 30, 2025, 8:00 AM EDT - 3 months ago

Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025

May 22, 2025, 11:45 AM EDT - 4 months ago

Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History

May 8, 2025, 3:08 AM EDT - 4 months ago

Fresenius Medical Care AG (FMS) Q1 2025 Earnings Conference Call Transcript

May 6, 2025, 7:00 AM EDT - 4 months ago

Fresenius Medical Care starts 2025 with strong organic revenue and income growth

May 6, 2025, 1:04 AM EDT - 4 months ago

Fresenius Medical Care tops market expectations in 1st quarter

Apr 9, 2025, 6:32 PM EDT - 5 months ago

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

ABBV AMGN AZN BMY GSK JNJ LLY

Mar 13, 2025, 8:00 AM EDT - 6 months ago

Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum

Mar 4, 2025, 3:57 AM EST - 6 months ago

Fresenius Medical Care's stock falls on Fresenius' stake sale

Feb 25, 2025, 2:59 PM EST - 7 months ago

Fresenius Medical Care AG (FMS) Q4 2024 Earnings Conference Call Transcript

Feb 25, 2025, 7:00 AM EST - 7 months ago

Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025

Feb 25, 2025, 1:14 AM EST - 7 months ago

Fresenius Medical Care slightly beats market estimates in fourth quarter

Feb 24, 2025, 8:00 AM EST - 7 months ago

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

DGX

Jan 31, 2025, 6:20 AM EST - 8 months ago

Fresenius Medical Care: A 'Buy' Going Into 2025

Dec 23, 2024, 9:00 AM EST - 9 months ago

Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index

Dec 20, 2024, 11:23 AM EST - 9 months ago

Fresenius Medical Care returns to Dax 40 Index

Nov 5, 2024, 8:33 PM EST - 11 months ago

Hard work paying off despite challenges from U.S. weather-related events: Fresenius Medical Care CEO

Nov 5, 2024, 2:34 PM EST - 11 months ago

Fresenius Medical Care AG (FMS) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 7:00 AM EST - 11 months ago

Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024

Oct 21, 2024, 11:04 AM EDT - 11 months ago

Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024

Oct 4, 2024, 4:04 PM EDT - 1 year ago

Fresenius Medical Care: Let's Look At The Upside

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Fresenius Medical Care Grows Number of U.S. Patients Using Company's Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe Software

Jul 30, 2024, 9:30 PM EDT - 1 year ago

Fresenius Medical Care CEO says strategy is working as company delivers on transformation efforts

Jul 30, 2024, 12:39 PM EDT - 1 year ago

Fresenius Medical Care AG (FMS) Q2 2024 Earnings Call Transcript

Jul 30, 2024, 7:00 AM EDT - 1 year ago

Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024

Jul 13, 2024, 9:16 AM EDT - 1 year ago

US FTC probing DaVita, Fresenius Medical, Politico reports

DVA

Jun 25, 2024, 6:15 AM EDT - 1 year ago

Fresenius Medical Care: Significant Upside Remains

Jun 12, 2024, 8:00 AM EDT - 1 year ago

Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations

May 23, 2024, 12:33 PM EDT - 1 year ago

Moody's and S&P change Fresenius Medical Care's rating outlook to stable

May 21, 2024, 10:00 AM EDT - 1 year ago

Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024

May 16, 2024, 9:55 AM EDT - 1 year ago

Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth Targets

May 11, 2024, 6:42 AM EDT - 1 year ago

Fresenius Medical sees up to 2% US dialysis growth by year-end

May 7, 2024, 2:53 PM EDT - 1 year ago

Fresenius Medical Care AG (FMS) Q1 2024 Earnings Call Transcript

May 7, 2024, 10:30 AM EDT - 1 year ago

We have positive momentum in operating performance: Fresenius Medical Care CEO

May 7, 2024, 7:00 AM EDT - 1 year ago

Fresenius Medical Care starts the year with strong earnings growth

May 7, 2024, 4:08 AM EDT - 1 year ago

Fresenius Medical beats earnings expectations, keeps outlook; shares sink

Mar 22, 2024, 8:00 AM EDT - 1 year ago

Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care

Mar 19, 2024, 8:00 AM EDT - 1 year ago

Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device

Mar 13, 2024, 10:00 AM EDT - 1 year ago

Fresenius Medical Care appoints Jörg Häring as new Management Board member responsible for Legal, Compliance and Human Resources

WARRENBUFFETSIGNAL Sep. 9 at 7:22 PM

$CRMD $DVA $FMS BULLISH CORMEDIX

0 · Reply

Noname2022 Sep. 9 at 6:41 PM

$CRMD $FMS $DVA Great to have patient advocacy orgs backing a life saving preventive FDA approved Defencath for CVC’s Available at Fresenius but NOT Davita!

1 · Reply

Noname2022 Sep. 5 at 11:09 PM

$CRMD $DVA $FMS Fact: DefenCath cuts infections by 71%. It’s on formulary at Fresenius — not at DaVita.

2 · Reply

Noname2022 Sep. 5 at 1:46 AM

0 · Reply

Noname2022 Sep. 5 at 1:24 AM

0 · Reply

Noname2022 Sep. 4 at 1:52 PM

$CRMD $DVA $FMS https://www.tandfonline.com/doi/abs/10.1080/17460913.2025.2547498

0 · Reply

Estimize Sep. 4 at 11:06 AM

Wall St is expecting 0.58 EPS for $FMS Q3 [Reporting 11/04 BMO] http://www.estimize.com/intro/fms?chart=historical&metric_name=eps&utm_cont

0 · Reply

Noname2022 Sep. 3 at 6:45 PM

0 · Reply

JarvisFlow Sep. 2 at 12:30 PM

UBS has adjusted their stance on Fresenius Medical Care ( $FMS ), setting the rating to Sell.

0 · Reply

Noname2022 Aug. 31 at 9:11 AM

$CRMD $FMS $DVA Just a reminder…

0 · Reply

Noname2022 Aug. 30 at 5:46 PM

$CRMD $FMS

0 · Reply

Noname2022 Aug. 29 at 10:32 PM

$CRMD $FMS

2 · Reply

Noname2022 Aug. 29 at 12:54 PM

$CRMD $FMS $DVA Life saving medication available at Fresenius ***Not at Davita***

2 · Reply

Noname2022 Aug. 28 at 9:34 PM

$CRMD $FMS

1 · Reply

Noname2022 Aug. 28 at 7:54 PM

$CRMD $FMS A patient (13.5K followers) talking about defencath being available at Fersenius *you can watch on the web, no account needed

0 · Reply

Noname2022 Aug. 28 at 2:14 AM

$CRMD $FMS https://www.instagram.com/reel/DN0yNo3Yn-W/?igsh=YjhxYnZxaTB1dzhn

2 · Reply

1Knevrenuff Aug. 13 at 1:48 PM

$FMS ...feel free to start that share buy back you promised us

0 · Reply

BULLZ820 Aug. 12 at 10:51 PM

$FMS they need to get everyone switched over to Vafseo as soon as possible unless they want more scandals coming out about not providing patients with the best medication and care possible because of business interests. All tho during Vafseo tdapa they would greatly benefit from using Vafseo over esa

0 · Reply

1Knevrenuff Aug. 11 at 2:23 PM

$FMS

0 · Reply

1Knevrenuff Aug. 8 at 2:12 PM

$FMS

0 · Reply

1Knevrenuff Aug. 7 at 8:51 PM

$FMS ...let the share buybacks commence

0 · Reply

1Knevrenuff Aug. 7 at 4:13 PM

$FMS ...

0 · Reply

Market Cap	14.65B
Revenue (ttm)	20.92B
Net Income (ttm)	582.08M
EPS (ttm)	N/A
PE Ratio	13.37
Forward PE	11.34
Profit Margin	2.78%
Debt to Equity Ratio	0.51

Volume	342,600
Avg Vol	289,306
Day's Range	N/A - N/A
Shares Out	586.83M
Stochastic %K	68%
Beta	0.90
Analysts	Sell
Price Target	$27.04